HIV subtypes induce distinct profiles of HIV-specific CD8+ T cell responses

AIDS Research and Human Retroviruses

Volumn 24, Issue 2, 2008, Pages 283-287

  Baker, Chris A R ^a   McEvers, Kimberly ^a   Byaruhanga, Rose ^b   Mulindwa, Rwabaingi ^b   Atwine, Diana ^b   Nantiba, Josephine ^b   Jones, Norman G ^a   Ssewanyana, Isaac ^b   Cao, Huyen ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAG PROTEIN; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MALE; UGANDA;

EID: 39549106019     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0183     Document Type: Article

References (34)

1. Goulder PJ and Watkins DI: HIV and SIV CTL escape: Implications for vaccine design. Nat Rev Immunol 2004;4:630-640.
2. Betts MR, Ambrozak DR, Douek DC, et al.: Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001;75:11983-11991.
3. Addo MM, Yu XG, Rathod A, et al.: Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific Tcell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003;77:2081-2092.
4. Goulder PJ, Tang Y, Brander C, et al.: Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 2000;192:1819-1832.
5. Betts MR, Nason MC, West SM, et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781-4789.
6. Appay V, Nixon DF, Donahoe SM, et al.: HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
7. Goepfert PA, Bansal A, Edwards BH, et al.: A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 2000;74:10249-10255.
8. Kostense S, Ogg GS, Manting EH, et al.: High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: Evidence for impaired CTL effector function. Eur J Immunol 2001;31:677-686.
9. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, and Lieberman J: Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood 2000;96:3094-3101.
10. Champagne P, Ogg GS, King AS, et al.: Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410:106-111.
11. Bruce C, Clegg JC, Featherstone A, et al.: Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res Hum Retroviruses 1994;10:1543-1550.
12. Hoelscher M, Dowling WE, Sanders-Buell E, et al.: Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS 2002;16:2055-2064.
13. Hu DJ, Dondero TJ, Rayfield MA, et al.: The emergeing genetic diversity of HIV. The importance of global surveillance for diagnostics, research and prevention. JAMA 1996;275:210-216.
14. Kaleebu P, Ross A, Morgan D, et al.: Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001;15:293-299.
15. Kaleebu P, French N, Mahe C, et al.: Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002;185:1244-1250.
16. Richard N, Juntilla M, Abraha A, et al.: High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2004;20:355-364.
17. Vasan A, Renjifo B, Hertzmark E, et al.: Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006;42:843-852.
18. Baeten JM, Chohan B, Lavreys L, et al.: HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007;195:1177-1180.
19. Eggena MP, Barugahare B, Jones N, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407-4414.
20. Eggena MP, Barugahare B, Okello M, et al.: T cell activation in HIV-seropositive Ugandans: Differential associations with viral load, CD4+ T cell depletion, and coinfection. J Infect Dis 2005;191:694-701.
21. Jones N, Eggena M, Baker C, et al.: Presence of distinct subsets of cytolytic CD8+ T cells in chronic HIV infection. AIDS Res Hum Retroviruses 2006;22:1007-1013.
22. Barugahare B, Baker C, K'Aluoch O, et al.: Human immunodeficiency virus-specific responses in adult Ugandans: Patterns of cross-clade recognition. J Virol 2005;79:4132-4139.
23. Peters PJ, Borst J, Oorschot V, et al.: Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991;173:1099-1109.
24. Barry M and Bleackley RC: Cytotoxic T lymphocytes: All roads lead to death. Nat Rev Immunol 2002;2:401-409.
25. Betts MR, Brenchley JM, Price DA, et al.: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
26. Betts MR, Price DA, Brenchley JM, et al.: The functional profile of primary human antiviral CD8 T cell effector activity is dictated by cognate peptide concentration. J Immunol 2004;172:6407-6417.
27. Zhang JY, Zhang Z, Wang X, et al.: PD-1 upregulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors, but not in long-term non-progressors. Blood 2007;109:4671-4678.
28. Trautmann L, Janbazian L, Chomont N, et al.: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.
29. Novitsky V, Gilbert P, Peter T, et al.: Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003;77:882-890.
30. Frahm N, Korber BT, Adams CM, et al.: Consistent cytotoxic-Tlymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004;78:2187-2200.
31. Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, and Goepfert PA: Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002;76:2298-2305.
32. Gea-Banacloche JC, Migueles SA, Martino L, et al.: Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 2000;165:1082-1092.
33. Cao H, Mani I, Vincent R, et al.: Cellular immunity to HIV-1 clades: Relevance to HIV-1 vaccine trials in Uganda. J Infect Dis 2000;182:1350-1356.
34. Jones N, Agrawal D, Elrefaei M, et al.: Evaluation of antigen-specific responses using in vitro enriched T cells. J Immunol Methods 2003;274:139-147.